Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

European Society
For Medical Oncology

The leading professional organisation for medical oncology

Abstract deadline 10 May 2023
Abstract deadline 10 May 2023

ESMO Congress 2023

The place to share your research, explore promising areas of development and engage with the international oncology community

Submit your abstract
Early registration fee until 24 April
Early registration fee until 24 April

ESMO Examination 2023

A valuable assessment tool for practicing medical oncologists and an excellent opportunity for medical oncologists in training to assess their knowledge. 

Register now
Best practice recommendations
Best practice recommendations

Oesophageal Cancer: Guidelines Webinar

Discover how the ESMO Guidelines can assist in your decision making to optimise patient care. ESMO Member? Take the CME test and get 1 ESMO-MORA category 1 point

Access now
On-demand Resources
On-demand Resources

March ESMO Virtual Plenary

Access the resources for this striking presentation of practice-changing data in advanced endometrial cancer 

Watch Now
ESMO-MCBS 1000x1000


A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.

Discover more

Latest News

Daily Reporter

Clean air is essential to prevent lung cancer

ESMO is contributing to making European Union legislation stricter on exposure limits for air pollution and asbestos to prevent new lung cancer cases 

Daily Reporter

Mesothelioma treatment: from hopeless to hopeful

Recipient of the Heine H. Hansen Award 2023, Prof. Paul Baas charts the course of mesothelioma treatment over the last 30 years and warns that progress has been made only in some areas of the world  

Read the ESMO Daily Reporter
Read the ESMO Daily Reporter More Oncology News More Press Releases More Society Updates
More Oncology News
Press Releases Event Announcement

ESMO Targeted Anticancer Therapies Congress 2023

The ESMO Targeted Anticancer Therapies Congress 2023, the gathering focusing on promising new anticancer targets and agents, with a particular emphasis on those in early phase clinical development, will be held in Paris, France, on 6-8 March 2023.

Press Releases Event Announcement

ESMO Gynaecological Cancers Congress 2023

The ESMO Gynaecological Cancers Congress 2023, the annual event dedicated to improving the practice of gynaecological cancers specialists worldwide, will provide an overview of the latest treatments as well as insights into the biology and biomarkers of ovarian, uterine, cervical and even rare gynaecological cancers.

Press Releases Event Announcement

ESMO Immuno-Oncology Congress 2022, 7-9 December, Geneva, Switzerland

The ESMO Immuno-Oncology Congress 2022, an annual congress dedicated to the presentation and discussion of the latest scientific developments in this fast-moving field, will be held in person in Geneva, Switzerland, and virtually between 7-9 December.

More Press Releases
Society Updates Society Updates

2023 Heine H. Hansen Award Recipient Announced

The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced today that the 2023 Heine H. Hansen Award is conferred on Paul Baas for his outstanding contribution to thoracic oncology research

Society Updates Society Updates

ESMO Supports World Cancer Day 2023

ESMO renews its support to World Cancer Day (WCD) joining the #CloseTheCareGap campaign led by the Union for International Cancer Control (UICC). 

Society Updates

ESMO Award for Immuno-Oncology 2022 Recipient Announced

The European Society for Medical Oncology (ESMO) has announced today that the winner of the ESMO Award for Immuno-Oncology 2022 is conferred on Nina Bhardwaj for her outstanding contribution to cancer immunology research.

More Society Updates

Congress Scientific Watch

Liposomal Irinotecan Fails To Extend Advanced SCLC Survival

From ELCC 2023:
Liposomal irinotecan does not offer significantly better overall survival than topotecan for patients with small-cell lung cancer that has progressed during or after first-line platinum-based chemotherapy 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.